MIGNARRI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 7.026
EU - Europa 4.316
AS - Asia 2.000
SA - Sud America 356
Continente sconosciuto - Info sul continente non disponibili 180
AF - Africa 134
OC - Oceania 3
Totale 14.015
Nazione #
US - Stati Uniti d'America 6.938
GB - Regno Unito 1.279
RU - Federazione Russa 781
CN - Cina 693
SG - Singapore 628
IT - Italia 551
IE - Irlanda 477
BR - Brasile 294
UA - Ucraina 278
SE - Svezia 242
DE - Germania 214
FR - Francia 198
VN - Vietnam 177
HK - Hong Kong 156
FI - Finlandia 100
ZA - Sudafrica 81
KR - Corea 73
ES - Italia 60
BD - Bangladesh 55
TR - Turchia 55
CA - Canada 42
IN - India 35
NL - Olanda 30
PL - Polonia 26
BE - Belgio 23
PK - Pakistan 21
MX - Messico 20
IQ - Iraq 19
AR - Argentina 16
JP - Giappone 16
CO - Colombia 12
ID - Indonesia 12
IL - Israele 11
LT - Lituania 11
MA - Marocco 10
SA - Arabia Saudita 10
EC - Ecuador 9
DZ - Algeria 8
EG - Egitto 8
NG - Nigeria 7
PE - Perù 7
VE - Venezuela 7
EU - Europa 6
JM - Giamaica 6
SK - Slovacchia (Repubblica Slovacca) 6
CI - Costa d'Avorio 5
CZ - Repubblica Ceca 5
GR - Grecia 5
HN - Honduras 5
KE - Kenya 4
KZ - Kazakistan 4
PH - Filippine 4
PT - Portogallo 4
TN - Tunisia 4
AT - Austria 3
AZ - Azerbaigian 3
BG - Bulgaria 3
BO - Bolivia 3
CR - Costa Rica 3
IR - Iran 3
MD - Moldavia 3
MK - Macedonia 3
PY - Paraguay 3
SV - El Salvador 3
UY - Uruguay 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
CL - Cile 2
DK - Danimarca 2
ET - Etiopia 2
HU - Ungheria 2
JO - Giordania 2
KW - Kuwait 2
LB - Libano 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
RO - Romania 2
SC - Seychelles 2
SI - Slovenia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GD - Grenada 1
KG - Kirghizistan 1
LV - Lettonia 1
LY - Libia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
Totale 13.836
Città #
Southend 1.131
Dallas 1.092
Fairfield 675
Menlo Park 504
Ashburn 488
Dublin 475
Woodbridge 337
Singapore 328
Chandler 273
San Jose 271
Wilmington 253
Seattle 249
Santa Clara 248
Houston 247
Jacksonville 243
Moscow 241
Cambridge 228
Beijing 197
Ann Arbor 190
Milan 161
Hong Kong 150
Council Bluffs 114
Princeton 96
Siena 95
Los Angeles 83
Hefei 79
Johannesburg 79
New York 71
Seoul 71
Nanjing 70
The Dalles 60
Ho Chi Minh City 55
Munich 54
Málaga 52
Rome 45
Helsinki 44
Lauterbourg 44
Boardman 43
Lancaster 42
San Diego 40
Izmir 33
North Bergen 33
Buffalo 31
Hanoi 31
Columbus 29
Dong Ket 29
San Mateo 26
Orem 24
Nanchang 23
Changsha 22
London 22
Warsaw 22
Florence 20
Hebei 20
Tianjin 19
Shenyang 18
Figino 17
Shanghai 17
São Paulo 17
Brussels 16
Chicago 16
Dearborn 15
Jiaxing 14
Phoenix 14
San Francisco 14
Tokyo 14
Turku 14
Montreal 13
Redondo Beach 13
Toronto 13
Boston 12
Brooklyn 12
Düsseldorf 12
Norwalk 12
Frankfurt am Main 11
Washington 11
Kunming 10
Turin 10
Atlanta 9
Belo Horizonte 9
Stockholm 9
Bologna 8
Brasília 8
Guangzhou 8
Hangzhou 8
Jinan 8
Bengaluru 7
Da Nang 7
Denver 7
Lahore 7
Manchester 7
Richland 7
Waanrode 7
Abuja 6
Baghdad 6
Bratislava 6
Carrboro 6
Mestre 6
Mumbai 6
Naples 6
Totale 10.075
Nome #
An atypical case of Creutzfeldt-Jakob disease mimicking frontotemporal dementia: genotypic influence and clinical implications 492
A CASE OF CEREBROTENDINOUS XANTHOMATOSIS PRESENTING WITH PARKINSONISM IN THE SEVENTH DECADE 422
A mimic of first dorsal interosseus atrophy revealed by ultrasound study 333
Cerebellum and neuropsychiatric disorders: insights from ARSACS 331
Double trouble? Progranulin mutation and C9ORF72 repeat expansion in a case of primary non-fluent aphasia 331
Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis 300
Zellweger Spectrum Disorder with Mild Phenotype Caused by PEX2 Gene Mutations 299
Eye movement abnormalities in a patient with Zellweger spectrum disorder 298
Cerebellar hypometabolism with normal structural findings in Cerebrotendinous xanthomatosis. A case report 295
Narcolepsy is a common phenotype in HSAN IE and ADCA-DN 292
The role of dentate nuclei in human oculomotor control: Insights from cerebrotendinous xanthomatosis 290
Mitochondrial dysfunction in hereditary spastic paraparesis with mutations in DDHD1/SPG28 286
Brain metabolism changes after therapy with chenodeoxycholic acid in a case of cerebrotendinous xanthomatosis. 281
Demyelinating polyneuropathy in a case of anti-LGI1 encephalitis 277
Cerebrotendinous xanthomatosis with progressive cerebellar vacuolation. Six-year MRI follow-up 272
Temporal lobe abnormalities in neurosyphilis 270
Two-year follow-up after chelating therapy in a patient with adult-onset parkinsonism and hypermanganesaemia due to SLC30A10 mutations 268
Imaging of the thymus in myotonic dystrophy type 1 262
The first Italian patient with oculopharyngodistal myopathy: Case report and considerations on differential diagnosis. 261
Primary familial brain calcification: Genetic analysis and clinical spectrum. 260
A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis. 253
Electrodiagnosis in cranial botulism 251
Mutations in SLC30A10 Cause Parkinsonism and Dystonia with Hypermanganesemia, Polycythemia, and Chronic Liver Disease. 249
Polyneuropathy with demyelinating changes in Churg–Strauss syndrome: an unusual association 249
The spectrum of magnetic resonance findings in cerebrotendinous xanthomatosis: redefinition and evidence of new markers of disease progression 242
Long-Term Bone Density Evaluation in Cerebrotendinous Xanthomatosis: Evidence of Improvement after Chenodeoxycholic Acid Treatment. 237
Clinical Features and Outcome of the Guillain–Barre Syndrome: A Single-Center 11-Year Experience 236
Hand muscles corticomotor excitability in hereditary spastic paraparesis type 4. 236
First report of an Iraqi Kurdish CADASIL patient. 235
Hereditary spastic paraplegia type 5: a potentially treatable disorder of cholesterol metabolism 234
Myoclonus epilepsy, retinitis pigmentosa, leukoencephalopathy and cerebral calcifications associated with a novel m.5513G>A mutation in the MT-TW gene 232
Neuroendocrine lung cancer in a patient with limbic encephalopathy due to anti-Hu antibodies: A rare association not to be missed 231
Parkinsonism as neurological presentation of late-onset cerebrotendinous xanthomatosis 229
Next Generation Molecular Diagnosis of Hereditary Spastic Paraplegias: An Italian Cross-Sectional Study 227
Polyneuropathy in cerebrotendinous xanthomatosis and response to treatment with chenodeoxycholic acid. 226
Lithium neurotoxicity mimicking rapidly progressive dementia 226
Brachial plexopathy due to breast cancer metastases: electrophysiological and imaging findings 220
A Novel CSF1R Mutation in a Patient with Clinical and Neuroradiological Features of Hereditary Diffuse Leukoencephalopathy with Axonal Spheroids 218
Discordant manifestations in Italian brothers with GNE myopathy 215
SPG5 siblings with different phenotypes showing reduction of 27-hydroxycholesterol after simvastatin-ezetimibe treatment 182
From the liver to the brain: manganese matters : Focus on cirrhosis-related Parkinsonism. 176
null 155
null 146
null 144
null 143
Enlarging brain xanthomas in a patient with cerebrotendinous xanthomatosis. 134
Mitochondrial recessive ataxia syndrome: A neurological rarity not to be missed. 132
Ataxia with oculomotor apraxia type 2: not always an easy diagnosis 130
The safety and effectiveness of chenodeoxycholic acid treatment in patients withcerebrotendinous xanthomatosis:two retrospective cohort studies 125
Correction to: Monoallelic KIF1A-related disorders: a multicenter cross sectional study and systematic literature review 123
Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis 123
null 123
Erratum: Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1 (Scientific Reports (2016) 6 (38174) DOI: 10.1038/srep38174) 123
Correction to: Monoallelic KIF1A-related disorders: a multicenter cross sectional study and systematic literature review (Journal of Neurology, (2022), 269, 1, (437-450), 10.1007/s00415-021-10792-3) 121
null 119
Familial Alzheimer’s disease associated with heterozygous NPC1 mutation 118
Primary familiall brain calcification caused by MYORG mutations in an Italian family 114
Oculomotor features in SCA27B patients 112
null 109
null 108
null 107
Primary familial brain calcification with mild phenotype due to a new PDGFB mutation 107
null 92
Treatment of SPG5 with cholesterol-lowering drugs 82
Syntactic complexity in Mild Cognitive Impairment due to Alzheimer’s disease (MCI-AD): long-distance dependencies and working memory in comprehension of relative clauses 80
Neuromuscular excitability changes produced by sustained voluntary contraction and response to mexiletine in myotonia congenita 76
Multiple sclerosis and chronic progressive external ophthalmoplegia associated with a large scale mitochondrial DNA single deletion 73
Primary familial brain calcification: update on molecular genetics 72
Totale 14.015
Categoria #
all - tutte 38.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.541


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022538 0 0 0 41 47 26 49 17 48 85 76 149
2022/2023981 58 66 133 125 106 192 21 77 105 58 22 18
2023/2024677 36 21 58 30 17 192 246 15 3 13 4 42
2024/20251.479 17 73 136 60 227 102 64 66 130 42 153 409
2025/20264.197 283 532 910 434 703 114 316 117 139 206 94 349
2026/2027701 167 127 263 144 0 0 0 0 0 0 0 0
Totale 14.015